External Ventricular Drain

Global External Ventricular Drain Market to Reach US$9.0 Billion by 2030

The global market for External Ventricular Drain estimated at US$7.1 Billion in the year 2024, is expected to reach US$9.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Pediatric, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Adult segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 7.2% CAGR

The External Ventricular Drain market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global External Ventricular Drain Market - Key Trends & Drivers Summarized

What Are External Ventricular Drains and Why Are They Crucial in Neurology?

External ventricular drains (EVDs) are critical medical devices used in neurosurgery and intensive care units (ICUs) to relieve intracranial pressure caused by conditions such as traumatic brain injury, hydrocephalus, intracranial hemorrhage, and brain tumors. These drains temporarily divert excess cerebrospinal fluid (CSF) from the brain’s ventricles to an external drainage system, preventing life-threatening complications such as brain herniation. As neurological disorders and head trauma cases increase globally, the demand for EVDs continues to rise.

The importance of EVDs in critical care settings cannot be overstated, as they provide an immediate solution for managing elevated intracranial pressure, allowing healthcare providers to stabilize patients and monitor their neurological status effectively. These devices play a vital role in neurosurgical procedures and postoperative care, where precise CSF drainage and pressure regulation are necessary. The growing incidence of stroke, aneurysms, and neurocritical conditions has made EVDs indispensable in modern neurosurgical practices, leading to increased investments in research and innovation.

How Is Technology Improving External Ventricular Drain Systems?

Advancements in medical technology have led to significant improvements in EVD systems, enhancing their accuracy, safety, and ease of use. Traditional EVDs require manual adjustments by healthcare professionals, but modern devices now incorporate digital monitoring systems that allow for automated and precise regulation of CSF drainage. These smart EVDs are equipped with pressure sensors and electronic valve systems, reducing the risk of over-drainage or under-drainage, which can lead to serious complications such as brain collapse or continued intracranial hypertension.

In addition to automation, infection control remains a key area of innovation in EVD technology. Since EVDs involve direct access to the brain, they pose a high risk of infections such as ventriculitis. To mitigate this risk, manufacturers are developing antimicrobial-coated catheters and closed-system drainage setups that minimize bacterial contamination. The integration of biocompatible and antimicrobial materials not only enhances patient safety but also reduces the frequency of catheter-related infections, leading to better patient outcomes and shorter hospital stays.

What Are the Key Drivers of Growth in the External Ventricular Drain Market?

The external ventricular drain market is expanding due to increasing cases of neurological disorders, advancements in neurosurgical techniques, and heightened awareness of the importance of early intervention in neurocritical care. The rising prevalence of traumatic brain injuries caused by accidents, sports injuries, and falls—particularly among aging populations—has significantly increased the demand for EVD systems. Additionally, improvements in neurosurgical infrastructure, particularly in emerging markets, are facilitating the wider adoption of these life-saving devices.

The growth in the external ventricular drain market is driven by several factors, including technological advancements in smart monitoring systems, increasing investments in neurocritical care, and the rising incidence of stroke and traumatic brain injuries. Hospitals and healthcare providers are prioritizing patient safety and infection prevention, prompting the adoption of EVDs with antimicrobial properties and automated pressure regulation systems. Additionally, government initiatives and research funding aimed at improving neurosurgical outcomes are accelerating the development of next-generation EVDs. As the demand for precise and safer neurological interventions continues to grow, the external ventricular drain market is expected to witness sustained expansion, driven by innovation, improved healthcare accessibility, and advancements in medical device technology.

SCOPE OF STUDY:

The report analyzes the External Ventricular Drain market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Patient (Pediatric, Adult); Application (Traumatic Brain Injury Application, Subarachnoid Hemorrhage Application, Intracerebral Hemorrhage Application, Non-Traumatic Hydrocephalus Condition Application)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• B. Braun Melsungen AG
• Biometrix
• Boston Neurosciences
• Chongqing Xinsheng Medical Instrument Co., Ltd.
• Delta Surgical Limited
• Dispomedica GmbH
• Fuji Systems Corporation
• G. Surgiwear Ltd.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• KFF S.A.
• Medikit Co., Ltd.
• Medtronic plc
• Möller Medical GmbH
• Natus Medical Incorporated
• Neuromedex GmbH
• Orsan Medical Technologies
• Sophysa
• Spiegelberg GmbH & Co. KG
• Zhejiang Kindly Medical Devices Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.